1 / 19

Biological Treatment for Periodontal Regeneration

Biological Treatment for Periodontal Regeneration. Use of growth and differentiation factors Reference: Lindhe (5 th ed), pp 938-940. Human BMP-2 (INFUSE ® ). Action: stimulation of bone formation via recombinant human bone morphogenetic protein-2

danton
Download Presentation

Biological Treatment for Periodontal Regeneration

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biological Treatment for Periodontal Regeneration Use of growth and differentiation factors Reference: Lindhe (5th ed), pp 938-940

  2. Human BMP-2 (INFUSE®) • Action: stimulation of bone formation via recombinant human bone morphogenetic protein-2 • With INFUSE, rhBMP-2 powder is mixed with sterile water and applied to collagen sponges

  3. Regeneration of a peri-implant bone defect with INFUSE® Photos: Dr. Shaun Rotenberg

  4. Left: surgical access to osseous defect, with missing F and L wallsRight: decortication of bone to enhance nutrient supply

  5. Left: INFUSE® sponge positioned around implantRight: placement of bone graft

  6. Left: Bone graft covered with INFUSE® spongeRight: Closure of surgical site

  7. Radiographic assessment Pre-operative 2 month post-op 5 month post-op

  8. Enamel Matrix Derivative (Emdogain®) • Action: forms layer of extracellular matrix on the root surface that promotes selective cell colonization (enhances mesenchymal cell adhesion and inhibits epithelial cell adhesion) • Meta-analysis of 10 randomized clinical trials showed EMD significantly improved attachment levels (1.2 mm) and pocket reduction (0.8 mm) compared to placebo or control when assessed 1 year after application (Esposito et al, 2005) • Histological studies show formation of new bone, PDL and cementum in primate model

  9. Periodontal regeneration with Emdogain® Photos: Dr. Shaun Rotenberg

  10. Right: Osseous defect after debridement and root planingLeft: Removal of smear layer from root with PrefGel® prior to treatment of root surface with Emdogain®

  11. Placement of bone graft material coated with Emdogain®

  12. Facial and lingual views after suturing. Emdogain® was applied to marginal tissue and sutures

  13. Post-operative appearance 2 weeks after treatment with Emdogain®, showing accelerated healing of wound site

  14. Human Platelet-Derived Growth Factor in Tri-calcium Phosphate (GEM 21S ®) • Action: PDGF stimulates migration and proliferation of osteoblasts, fibroblasts and cementoblasts, leading to formation of new bone, PDL and cementum • Randomized clinical trial suggested that GEM 21S ® produced a significantly greater extent of radiographic bone fill, but did not significantly enhance attachment gain relative to control (tri-calcium phosphate alone)

  15. Upper panels: Facial and lingual views of surgical siteLower panels: Facial and lingual sulcular incisions Photos: Dr. Shaun Rotenberg

  16. Facial and Lingual views of osseous defect, showing severe furcational bone loss

  17. GEM 21S® delivery system

  18. Left: Placement of synthetic bone matrix (tricalcium phosphate) containing GEM 21S®Right: A collagen membrane was used to confine the graft and isolate the lingual osseous defect

  19. Facial and lingual view of sutured surgical site.

More Related